Research and Development: Page 3

Roche, Ascidian to develop gene therapies for neurological diseases

By LabPulse.com staff writers

Roche has announced a research collaboration and licensing agreement with biotech firm Ascidian Therapeutics to develop gene therapies for neurological diseases.

June 19, 2024

ALZpath, Roche sign licensing agreement for dementia biomarker

By LabPulse.com staff writers

ALZpath has signed a licensing agreement with Roche for the use of the ALZpath pTau217 antibody to develop and commercialize a diagnostic blood test for Alzheimer's disease that will be offered on the Roche Elecsys platform.

June 12, 2024

Qiagen, Myriad Genetics to develop HRD test

By LabPulse.com staff writers

As part of their recently announced collaboration, Qiagen and Myriad Genetics will develop a kit-based test for analyzing homologous recombination deficiency (HRD) status.

June 5, 2024

Genialis, PanCAN partner to validate KRAS biomarker for pancreatic cancer

By LabPulse.com staff writers

Biomarker company Genialis and the Pancreatic Cancer Action Network (PanCAN) are collaborating to further the validation of the Genialis KrasID biomarker for pancreatic cancer using PanCAN's Know Your Tumor precision medicine service.

June 3, 2024

GMU researchers receive $1.2M in funding for Lyme disease urine test

By LabPulse.com staff writers

Researchers at George Mason University (GMU) have received $1.2 million in federal funding from the U.S. Department of the Army to develop a urine-based test for the detection and diagnosis of Lyme disease.

May 24, 2024

Nanopath awarded $4M in SBIR grants

By LabPulse.com staff writers

Nanopath has announced that it has been awarded two grants worth a total of $4 million in federal funding through the Small Business Innovation Research (SBIR) program.

May 22, 2024

BioMarin confirms layoffs and R&D cuts

By LabPulse.com staff writers

Roctavian, BioMarin's gene therapy for severe hemophilia A, generated $800,000 in net product revenue in the first quarter of 2024.

May 15, 2024

Danaher launches collaboration with Johns Hopkins University on TBI diagnostics

By LabPulse.com staff writers

Danaher has launched a partnership with Johns Hopkins University aimed at developing new traumatic brain injury (TBI) diagnostics.

May 9, 2024

Novo Nordisk Foundation, Wellcome, Gates Foundation to partner on global health challenges

By LabPulse.com staff writers

The Novo Nordisk Foundation, Wellcome, and the Bill & Melinda Gates Foundation have announced a collaboration to support scientific research and development for accessible solutions to global health challenges.

May 6, 2024

Astellas and Poseida to collaborate on oncology cell therapies

By LabPulse.com staff writers

Poseida Therapeutics and Astellas, under its Xyphos Biosciences subsidiary, have initiated a research collaboration and licensing agreement to develop allogeneic cell therapy programs by combining their innovative cell therapy platforms and technologies.

May 2, 2024

GSK, Genomics PLC collaborate on polygenic risk score use for clinical trials

By LabPulse.com staff writers

Genomics PLC and biopharmaceutical firm GSK have established a collaboration aimed at assessing the potential for using polygenic risk scores in clinical trials.

May 1, 2024

Immunovia announces positive results for next-gen pancreatic cancer test

By LabPulse.com staff writers

Diagnostics company Immunovia announced positive results for the newest generation of its pancreatic cancer test from a model-development study, announcing that the test achieved both its primary and secondary endpoints.

April 25, 2024

Previous Page

Page 3 of 41

Next Page